A Study to Analyze the Effect of Cardioversion on the Tricuspid and Mitral Valves in Patients with Atrial Fibrillation

Overview

About this study

The purpose of this study is to assess the immediate effect of cardioversion on both the tricuspid and mitral annular dynamics and size in patients with atrial fibrillation, and to compare the annular dynamics and dimensions in both the tricuspid and mitral valves immediately before and after cardioversion in patients with atrial fibrillation using 3D transesophageal echocardiography.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients older than 18 years old.
  • Males or females.
  • Patients who came in for cardioversion for atrial fibrillation.

Exclusion Criteria: 

  • Poor image quality.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sorin Pislaru, M.D., Ph.D.

Open for enrollment

Contact information:

Sorin Pislaru M.D., Ph.D.

(507) 284-8612

Pislaru.Sorin@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20502623

Mayo Clinic Footer